News
Shares in Wave Life Sciences rose by 74% after it reported clinical data with a pioneering new RNA-editing therapy for alpha-1 antitrypsin deficiency (AATD). Wave claims this is the first clinical ...
I put the best video editing apps for mobile devices to the test - and if you want to cut content on a phone or tablet, these are the apps I recommend. If you want a professional-grade editing app ...
With the launch of the new Pixel 10 series, Google is rushing ahead of Apple to deliver AI-powered smartphones to consumers. The devices, announced during Wednesday’s Made by Google event, come just ...
Wave Life Sciences (NASDAQ:WVE) lost ~21% in the premarket on Wednesday after the company announced data from a Phase 1b/2a trial for its RNA-editing therapy WVE-006 developed with GSK (NYSE:GSK) for ...
Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results